(Q41719270)

English

Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes

scientific article published on 26 May 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

triple-negative breast cancer

1 reference

based on heuristic

inferred from title

author name string

Hee Jin Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Jeong-Ju Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

In Hye Song

3

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

In Ah Park

4

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Jun Kang

5

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Jong Han Yu

6

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Jin-Hee Ahn

7

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Gyungyub Gong

8

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

language of work or name

0 references

publication date

26 May 2015

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

151

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

619-627

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

https://scigraph.springernature.com/pub.10.1007/s10549-015-3438-8

0 references

Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Triple-negative breast cancer: clinical features and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Triple negative breast cancers: clinical and prognostic implications.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

High-grade breast cancers include both highly sensitive and highly resistant subsets to cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Effector memory T cells, early metastasis, and survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

The immune response against dying tumor cells: avoid disaster, achieve cure

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

CD4⁺ follicular helper T cell infiltration predicts breast cancer survival

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

The immune system and response to HER2-targeted treatment in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Direct multiplexed measurement of gene expression with color-coded probe pairs

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

GenePattern 2.0

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Leukocyte composition of human breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Dual roles for immune metagenes in breast cancer prognosis and therapy prediction

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

T follicular helper (TFH) cells in normal and dysregulated immune responses

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Inflammasome: cancer's friend or foe?

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

TLRs: linking inflammation and breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin C as a Compatible Prognostic Marker in Human Solid Tumors

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3438-8

21 January 2018

Identifiers

10.1007/S10549-015-3438-8

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41719270&oldid=1926255882"